U.S. Physical TherapyUSPH.NValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 16, 2026, U.S. Physical Therapy (USPH.N) trades at a P/E of 39.70x, P/B of 2.86x, P/S of 1.57x, and a dividend yield of 1.62%.
Longitudinal percentile comparison: P/E sits at the 52nd percentile over the trailing 10Y window (vs. 55th percentile over 3Y); P/B sits at the 24th percentile over the trailing 10Y window (vs. 78th percentile over 3Y); P/S sits at the 10th percentile over the trailing 10Y window (vs. 31st percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 73rd percentile within its industry and the 79th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 2.06%, ranking at the 84th percentile over the trailing 20Y window.
The P/E and P/B percentiles diverge here, differing by 27.4 points — relying on either metric alone could be misleading. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Breaking down the total shareholder yield: 1.62% comes from cash dividends, with an implied ~0.44% from buybacks — a fairly balanced mix of both channels. U.S. Physical Therapy operates in the Services sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: NYSE: USPH · USPH
Want the full picture on whether U.S. Physical Therapy (USPH.N) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 39.70 | ||||||
| P/B (MRQ) | 2.86 | ||||||
| P/S (TTM) | 1.57 | ||||||
| Dividend Yield | 1.62% | ||||||
| Buyback + Div Yield | 2.06% |